Recent research further highlights MEIS2’s role in calcific aortic valve disease (CAVD), where its inhibition promotes osteoblastic transdifferentiation and reduces Notch1 and Twist1 expression, making MEIS2 a potential target for CAVD prevention. This evidence concerns the gene NOTCH1 and congenital bilateral aplasia of vas deferens from CFTR mutation.